- Home
- ALLO vs IBCP Comparison
ALLO vs IBCP Comparison
Compare ALLO & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALLO | IBCP |
|---|---|---|
| Founded | 2017 | 1864 |
| Country | United States | United States |
| Employees | N/A | 270 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 703.3M |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ALLO | IBCP |
|---|---|---|
| Price | $2.06 | $35.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 2 |
| Target Price | $8.35 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 7.8M | 127.6K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.35% |
| EPS Growth | ★ 34.09 | 3.48 |
| EPS | N/A | ★ 0.81 |
| Revenue | N/A | ★ $32,075,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142,416.42 | $8.98 |
| P/E Ratio | ★ N/A | $43.47 |
| Revenue Growth | N/A | ★ 0.30 |
| 52 Week Low | $0.99 | $29.63 |
| 52 Week High | $4.46 | $37.39 |
Technical Indicators
Market Signals| Indicator | ALLO | IBCP |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 57.26 |
| Support Level | $1.85 | $32.22 |
| Resistance Level | $2.36 | $37.04 |
| Average True Range (ATR) | 0.13 | 0.84 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 74.12 | 69.03 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About IBCP Independent Bank Corporation
Independent Bank Corp. operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers. The firm's principal markets are the rural and suburban communities across Lower Michigan. The firm generates the majority of its revenue from Interest and fees on loans.